Overview2018-02-09T15:07:34+00:00
Mills Clinical Research

INNOVATION

Innovative focus on research and clinical trials to advance success in healthcare initiatives.

Action | Access | Innovation

Health Care, Education, Empowerment, Advocacy & Research

Mills Clinical Research is an advocate for men’s health, wellness and disease prevention for communities impacted by obstacles to healthcare, including awareness, health literacy and access.

Over the past decade, Dr. Mills has been the principal investigator in over 100 clinical trials. Many of these trials have led to presentations at national and international conferences and have been published in peer-reviewed medical journals.

Dedicated Professionals | Mills Clinical Research

Dedicated Professionals

We have a dedicated and diverse team of physicians and allied health professionals with expertise in the treatment of a wide range of therapeutic areas.

MEET THEM TODAY

State-of-the-Art Facilities | Mills Clinical Research

State-of-the-Art Facilities

We have a multi-specialty medical research site proficient in Phase I-IV clinical trials and our research team has conducted over 100 protocols.

VIEW THE TRIALS

Sponsors & CROs | Mills Clinical Research

Sponsors & CROs

We have an extensive network of sponsors and CROs, giving us the ability to partner with many other private practice physicians to augment recruitment of subjects.

BECOME A SPONSOR

0
years of experience

+

0
dedicated professionals

+

0k+
patient database

=

0
completed studies

First Man to Become HIV-Positive While on PrEP is Rare Exception

After tens of thousands of PrEP successes, the first documented case of someone becoming poz includes rare multiclass drug resistance.

It’s been nearly two years since the Centers for Disease Control and Prevention issued historic guidelines recommending that thousands of Americans—particularly gay and bi men, transgender women, injection drug users, and partners of HIV-positive individuals—start taking Truvada as pre-exposure prophylaxis (or PrEP) to prevent HIV infection.